111 related articles for article (PubMed ID: 21602254)
1. Adiponectin and sE-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease.
El-Mesallamy HO; Hamdy NM; Salman TM; Ibrahim SM
Angiology; 2012 Feb; 63(2):96-102. PubMed ID: 21602254
[TBL] [Abstract][Full Text] [Related]
2. Adiponectin and E-selectin concentrations in relation to inflammation in obese type 2 diabetic patients with coronary heart disease(s).
El-Mesallamy HO; Hamdy NM; Salman TM; Mahmoud S
Minerva Endocrinol; 2011 Sep; 36(3):163-70. PubMed ID: 22019747
[TBL] [Abstract][Full Text] [Related]
3. Adiponectin and pro-inflammatory cytokines in obese diabetic boys.
El-Mesallamy HO; Hamdy NM; Ibrahim SM
Indian Pediatr; 2011 Oct; 48(10):815-6. PubMed ID: 22080689
[TBL] [Abstract][Full Text] [Related]
4. Adiponectin, insulin resistance and clinical expression of the metabolic syndrome in patients with Type 2 diabetes.
Mojiminiyi OA; Abdella NA; Al Arouj M; Ben Nakhi A
Int J Obes (Lond); 2007 Feb; 31(2):213-20. PubMed ID: 16755284
[TBL] [Abstract][Full Text] [Related]
5. [Plasma level of adiponectin in coronary heart disease patients combined with abnormal glucose metabolism].
Xia K; Guo L; Zhao Z; Md Sayed AS; Li F; Yang T
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Feb; 37(2):179-84. PubMed ID: 22561436
[TBL] [Abstract][Full Text] [Related]
6. Plasma adiponectin and E-selectin concentrations in patients with coronary heart disease and newly diagnosed disturbances of glucose metabolism.
Kowalska I; Straczkowski M; Nikołajuk A; Kinalska I; Górska M; Prokop J; Bachórzewska-Gajewska H; Musiał W
Adv Med Sci; 2006; 51():94-7. PubMed ID: 17357284
[TBL] [Abstract][Full Text] [Related]
7. Acute hyperinsulinemia raises plasma interleukin-6 in both nondiabetic and type 2 diabetes mellitus subjects, and this effect is inversely associated with body mass index.
Ruge T; Lockton JA; Renstrom F; Lystig T; Sukonina V; Svensson MK; Eriksson JW
Metabolism; 2009 Jun; 58(6):860-6. PubMed ID: 19375766
[TBL] [Abstract][Full Text] [Related]
8. Which obesity index best explains the link between adipokines, coronary heart disease risk and metabolic abnormalities in type 2 diabetes mellitus?
Mojiminiyi OA; Al Mulla F; Abdella NA
Med Princ Pract; 2009; 18(2):123-9. PubMed ID: 19204431
[TBL] [Abstract][Full Text] [Related]
9. Relation of inflammatory chemokines to insulin resistance and hypoadiponectinemia in coronary artery disease patients.
Tretjakovs P; Jurka A; Bormane I; Mackevics V; Mikelsone I; Balode L; Reihmane D; Stukena I; Bahs G; Aivars JI; Pirags V
Eur J Intern Med; 2009 Nov; 20(7):712-7. PubMed ID: 19818293
[TBL] [Abstract][Full Text] [Related]
10. Serum visfatin and its relation to insulin resistance and inflammation in type 2 diabetic patients with and without macroangiopathy.
Alghasham AA; Barakat YA
Saudi Med J; 2008 Feb; 29(2):185-92. PubMed ID: 18246224
[TBL] [Abstract][Full Text] [Related]
11. Oxidative stress and platelet activation: markers of myocardial infarction in type 2 diabetes mellitus.
El-Mesallamy H; Hamdy N; Suwailem S; Mostafa S
Angiology; 2010; 61(1):14-8. PubMed ID: 19759031
[TBL] [Abstract][Full Text] [Related]
12. Association of impaired glucose metabolism in morbid obesity with hypoadiponectinaemia.
Schinner S; Kempf K; Overmann H; Willenberg HS; Schott M; Rose B; Scherbaum WA; Herder C
Exp Clin Endocrinol Diabetes; 2008 Sep; 116 Suppl 1():S64-9. PubMed ID: 18777458
[TBL] [Abstract][Full Text] [Related]
13. High plasma C-reactive protein (CRP) is related to low paraoxonase-I (PON-I) activity independently of high leptin and low adiponectin in type 2 diabetes mellitus.
Dullaart RP; de Vries R; Sluiter WJ; Voorbij HA
Clin Endocrinol (Oxf); 2009 Feb; 70(2):221-6. PubMed ID: 18505467
[TBL] [Abstract][Full Text] [Related]
14. Endothelial activation and inflammation in prepubertal obese Turkish children.
Süheyl Ezgü F; Hasanoğlu A; Tümer L; Ozbay F; Aybay C; Gündüz M
Metabolism; 2005 Oct; 54(10):1384-9. PubMed ID: 16154440
[TBL] [Abstract][Full Text] [Related]
15. Inflammation and type 2 diabetes.
Calle MC; Fernandez ML
Diabetes Metab; 2012 Jun; 38(3):183-91. PubMed ID: 22252015
[TBL] [Abstract][Full Text] [Related]
16. Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism.
Blüher M; Fasshauer M; Tönjes A; Kratzsch J; Schön MR; Paschke R
Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):534-7. PubMed ID: 16235156
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in the relationship between obesity, inflammation, and insulin resistance.
Bastard JP; Maachi M; Lagathu C; Kim MJ; Caron M; Vidal H; Capeau J; Feve B
Eur Cytokine Netw; 2006 Mar; 17(1):4-12. PubMed ID: 16613757
[TBL] [Abstract][Full Text] [Related]
18. Impact of biomarkers for endothelial dysfunction and procoagulant state on 10-year cardiovascular risk in Type 2 diabetes.
Natarajan A; Marshall SM; Kesteven PJ; McComb JM; Rutter MK
Diabet Med; 2011 Oct; 28(10):1201-5. PubMed ID: 21480978
[TBL] [Abstract][Full Text] [Related]
19. Similar to adiponectin, serum levels of osteoprotegerin are associated with obesity in healthy subjects.
Ashley DT; O'Sullivan EP; Davenport C; Devlin N; Crowley RK; McCaffrey N; Moyna NM; Smith D; O'Gorman DJ
Metabolism; 2011 Jul; 60(7):994-1000. PubMed ID: 21087777
[TBL] [Abstract][Full Text] [Related]
20. Effects of sitagliptin or metformin added to pioglitazone monotherapy in poorly controlled type 2 diabetes mellitus patients.
Derosa G; Maffioli P; Salvadeo SA; Ferrari I; Ragonesi PD; Querci F; Franzetti IG; Gadaleta G; Ciccarelli L; Piccinni MN; D'Angelo A; Cicero AF
Metabolism; 2010 Jun; 59(6):887-95. PubMed ID: 20015525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
